- ►nih.gov - Free from Publisher UHM Spandau, G Sauder, U Schubert, HP … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Methods: For in vitro analysis, a sprouting assay was employed. Bovine retinal
endothelial cells were stimulated with basic fibroblast growth factor (bFGF) and
incubated with different concentrations of triamcinolone acetonide (0.05 ... Cited by 28 - Related articles - All 9 versions
- ►bmj.com [PDF] PL Penfold - British Medical Journal, 2002 - bjo.bmj.com D ecisions based on clinical examina- tion are critical to the practice of
ophthalmology. Although quite dif- ferent disease processes can produce the same
structural and functional outcomes, treatment decisions are often directly ... Cited by 37 - Related articles - BL Direct - All 8 versions
H Gao, X Qiao, R Gao, WF Mieler, AR … - Vision Research, 2004 - Elsevier Intravitreal triamcinolone inhibits choroidal neovascularization. To investigate
if vascular endothelial growth factor (VEGF) is affected, we examined VEGF
expression after intravitreal triamcinolone administration in rat retina. ... Cited by 21 - Related articles - All 4 versions
- ►iovs.org ME Hartnett, DJ Martiniuk, Y Saito, P Geisen … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Newborn rats exposed to OIR underwent intravitreous injections (right
eye) at day 14 to achieve intravitreous concentrations of: dexamethasone (DEX)
(0.3 mg/mL), triamcinolone (TA; 0.4–4 mg/mL), or PBS. Animals were ... Cited by 12 - Related articles - BL Direct - All 5 versions
- ►spitalpharmazie-basel.ch [PDF] C Bitter, K Suter, V Figueiredo, C Pruente, K … - Journal of Ocular Pharmacology and Therapeutics, 2008 - liebertonline.com Objectives: All commercially available triamcinolone acetonide (TACA)
suspensions, used for intravitreal treatment, contain retinal toxic vehicles
(eg, benzyl alcohol, solubilizer). Our aim was to find a convenient and ... Cited by 5 - Related articles - BL Direct - All 6 versions
O Tatar, E Yoeruek, P Szurman, KU Bartz- … - Archives of ophthalmology, 2008 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 7 - Related articles - BL Direct - All 5 versions
O Tatar, A Adam, K Shinoda, E Yoeruek, P … - Retina, 2007 - journals.lww.com OLCAY TATAR, MD,* ANNEMARIE ADAM,† KEI SHINODA, MD, PHD,‡ EFDAL YOERUEK,
MD,* PETER SZURMAN, MD,* SILVIA BOPP, MD,§ CLAUS ECKARDT, MD,¶ KARL ULRICH
BARTZ-SCHMIDT, MD,* SALVATORE GRISANTI, MD* ... Purpose: To examine the ... Cited by 8 - Related articles - BL Direct - All 3 versions
Y Wang, U Friedrichs, W Eichler, S … - Graefe's Archive for Clinical and Experimental …, 2002 - Springer Abstract Background: Angiostatic drugs might provide desirable modu- lation of
choroidal angiogenesis-relat- ed diseases, including histoplasmosis and the
exudative form of age-related macular degeneration. However, the precise ... Cited by 81 - Related articles - BL Direct - All 3 versions
JB Jonas, UH Spandau, B Harder, U … - American journal of ophthalmology, 2005 - Elsevier In the study group, visual acuity increased significantly (P < 0.001) from 0.96
± 0.32 logMar to a mean maximum of 0.76 ± 0.30 logMar during follow-up. An
increase in best visual acuity during follow-up was found in 18 (90%) eyes. ... Cited by 22 - Related articles - All 10 versions
AN Antoszyk, JL Gottlieb, R Machemer, DL … - Graefe's Archive for Clinical and Experimental …, 1993 - Springer Abstract. Corticosteroids, alone or in combination with other drugs, have been
shown to inhibit angiogenesis. The purpose of this study was to evaluate the
efficacy of triamcinolone acetonide in a new model of preretinal ... Cited by 97 - Related articles - BL Direct - All 3 versions
